Pharma Journalist -

Acasti Pharma announced that it has received an invitation to present the CaPre (omega-3 phospholipid) study results at the National Lipid Association Scientific Sessions in…
Read More...

XOMA Corporation announced it has earned a $10 million milestone payment as one Company asset licensed to one of its pharmaceutical partners advances into clinical development. XOMA…
Read More...

Jubilant Life Sciences Ltd, announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, has received Abbreviated New Drug Application (ANDA)  final …
Read More...

The U.S. FDA has expanded approved use of Vertex Pharmaceuticals manufactured Kalydeco (ivacaftor) for treating cystic fibrosis. The approval triples the number of rare gene mutations…
Read More...

The U.S. FDA has granted Octapharma with orphan drug designation for Octagam 10%. Octagam 10% is an immune globulin intravenous (human) liquid for the treatment of…
Read More...

Cogstate Ltd announced that Eli Lilly’s has selected Cogstate as preferred provider for Alzheimer’s Disease Platform, to support with solutions to ensure high-quality neuropsychological…
Read More...

Concert Pharmaceuticals received notice from the U.S. FDA that its CTP-543 Phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA had previously…
Read More...

CytoDyn In. announced the treatment of the first patient suffering from GvHD(Graft versus Host Disease) with use of PRO 140 during its clinical trial Phase 2. The multicenter,…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Dr. Donna Morgan Murray has been appointed as Nativis Chief Regulatory Officer with immediate effective. Murray is author of more than 60 publications in peer-referenced…
Read More...